These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9117562)

  • 21. NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist.
    Dijk SN; Francis PT; Stratmann GC; Bowen DM
    Br J Pharmacol; 1995 Aug; 115(7):1169-74. PubMed ID: 7582540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acetylcholine excites neocortical pyramidal neurons via nicotinic receptors.
    Hedrick T; Waters J
    J Neurophysiol; 2015 Apr; 113(7):2195-209. PubMed ID: 25589590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.
    Ladner CJ; Lee JM
    Exp Neurol; 1999 Aug; 158(2):451-8. PubMed ID: 10415152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.
    Gronier B; Rasmussen K
    Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W; Gillberg PG; Nordberg A
    Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic localization of binding sites for muscarinic and nicotinic agonists and antagonists on cultured astrocytes.
    Hösli E; Hösli L
    Exp Brain Res; 1988; 71(2):450-4. PubMed ID: 3169176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analogues of carbacholine: synthesis and relationship between structure and affinity for muscarinic and nicotinic acetylcholine receptors.
    Søkilde B; Mikkelsen I; Stensbøl TB; Andersen B; Ebdrup S; Krogsgaard-Larsen P; Falch E
    Arch Pharm (Weinheim); 1996 Feb; 329(2):95-104. PubMed ID: 8851473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic receptor control of pyramidal neuron membrane potential in the medial prefrontal cortex (mPFC) in rats.
    Kurowski P; Gawlak M; Szulczyk P
    Neuroscience; 2015 Sep; 303():474-88. PubMed ID: 26186898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer's disease.
    Scarr E; McLean C; Dean B
    J Neural Transm (Vienna); 2017 Mar; 124(3):273-284. PubMed ID: 27688247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in dopamine D1 and D2 receptor binding in the substantia nigra following intrastriatal injection of a retrograde neurotoxin (volkensin).
    Black MD; Crossman AR
    Neurosci Lett; 1992 Jan; 134(2):180-2. PubMed ID: 1534159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of muscarinic agonists in the treatment of Alzheimer's disease.
    Messer WS
    J Mol Neurosci; 2002; 19(1-2):187-93. PubMed ID: 12212779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New approaches to imaging based on effects of neurotoxins.
    Francis PT; Chessell IP; Bowen DM
    Dement Geriatr Cogn Disord; 1997; 8(2):117-22. PubMed ID: 9065325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus.
    Rossner S; Schliebs R; Härtig W; Bigl V
    Brain Res Bull; 1995; 38(4):371-81. PubMed ID: 8535860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution of m1 muscarinic acetylcholine receptors in the hippocampus of patients with Alzheimer's disease and dementia with Lewy bodies-an immunohistochemical study.
    Shiozaki K; Iseki E; Hino H; Kosaka K
    J Neurol Sci; 2001 Dec; 193(1):23-8. PubMed ID: 11718746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cortical neurons contain both nicotinic and muscarinic acetylcholine receptors: an immunocytochemical double-labeling study.
    Schröder H; Zilles K; Luiten PG; Strosberg AD; Aghchi A
    Synapse; 1989; 4(4):319-26. PubMed ID: 2603150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of nicotinic and muscarinic receptor activation on patch-clamped cells in the optic tectum of Rana pipiens.
    Yu CJ; Debski EA
    Neuroscience; 2003; 118(1):135-44. PubMed ID: 12676145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study.
    Whitehouse PJ; Martino AM; Wagster MV; Price DL; Mayeux R; Atack JR; Kellar KJ
    Neurology; 1988 May; 38(5):720-3. PubMed ID: 3362368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia.
    Nordberg A; Alafuzoff I; Winblad B
    J Neurosci Res; 1992 Jan; 31(1):103-11. PubMed ID: 1613816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuronal degeneration by suicide transport following injection of volkensin into rat cerebral cortex.
    Heath PR; Chessell IP; Sanders MW; Francis PT; Bowen DM; Pearson RC
    Exp Neurol; 1997 Sep; 147(1):192-203. PubMed ID: 9294416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.